Coronavirus Notebook: WHO Backs Actemra & Kevzara In COVID-19, German Body Says Remdesivir Has ‘Considerable Added Benefit’
Executive Summary
The UK REACT-1 study has shown a threefold reduction in COVID-19 infections in double-vaccinated adults.
You may also be interested in...
EU Assessing Roche’s RoActemra For Hospitalized COVID-19 Patients
Three authorized products currently used for arthritis and other conditions have now been filed for approval in Europe for treating people with severe COVID-19.
Roche Under Fire Over ‘Unaffordable’ COVID-19 Therapy Actemra
The World Health Organization has taken the unusual step of calling for lower drug prices to help COVID-19 patients access IL-6 therapies in developing nations.
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.